Skip to content

Compare Outcomes of SMG and CPAP in OSA

A Randomized Cross-over Study of Adjustable Thermoplastic Oral Appliances and Continuous Positive Airway Pressure in Treatment of Patients With Obstructive Sleep Apnea

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02766179
Enrollment
50
Registered
2016-05-09
Start date
2014-10-31
Completion date
2016-12-31
Last updated
2016-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Sleep Apnea Syndromes

Brief summary

The objectives of this study is to compare short-term outcomes of CPAP and Adjustable thermoplastic oral appliance in the treatment of obstructive sleep apnea. Study design is a randomized cross-over trial during 6-week period of each treatment in 50 patients. Primary outcomes are quality of life, degree of sleepiness, and severity of OSA determined by FOSQ ESS, and AHI or RDI, respectively.

Detailed description

The objectives of this study is to compare short-term outcomes of CPAP and Adjustable thermoplastic oral appliance in the treatment of obstructive sleep apnea. Study design is a randomized cross-over trial during 6-week period of each treatment in 50 patients. Primary outcomes are quality of life, degree of sleepiness, and severity of OSA determined by FOSQ ESS, and AHI or RDI, respectively. Wash-in period 2 weeks and Wash-out periods 2 weeks are required before start each treatment.

Interventions

DEVICECPAP

CPAP is used for 6 weeks

DEVICESomnoguard

Somnoguard is used for 6 weeks

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. OSA patients aged over 18 YO at Siriraj hospital 2. AHI 5 - 30 events/ h or AHI \> 30 events/h but lowest O2 saturation \> 70% 3. Positive consented form

Exclusion criteria

1. Patients with severe Temporomandibular joint diseases or limited mandible advancement (\< 5 mm) 2. Patients with severe periodontal diseases or inadequate teeth (\< 3 teeth in each quadrant) 3. Patients with unstable medical problems i.e. poorly controlled cardiovascular diseases, COPD, cancers, cerebrovascular diseases, epilepsy, dementia, etc. 4. Patients who could not tolerate the side effects of CPAP or SMG 5. Patients who could not follow-up until finishing the protocol or withdraw themselves from the study for any reasons.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life6 weeksFOSQ scores

Secondary

MeasureTime frameDescription
side effects6 weeksquestionnaires
satisfaction6 weeksVAS scores
AHI6 weeksApnea-hypopnea index (events per hour)
Degree of sleepiness6 weeksESS scores
lowest oxygen saturation6 weekslowest oxygen saturation (%)

Countries

Thailand

Contacts

Primary ContactWish Banhiran, MD
wishbanh@hotmail.com6699756405

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026